Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Neuroprotective Activity of D-HES in Transient Global Cerebral Ischemia in Rats.

Anishchenko AM, Aliev OI, Sidekhmenova AV, Shamanaev AY, Kuchin AV, Chukicheva IY, Torlopov MA, Plotnikov MB.

Bull Exp Biol Med. 2018 Oct;165(6):728-730. doi: 10.1007/s10517-018-4252-1. Epub 2018 Oct 23.

PMID:
30353342
2.

Influence of pharmacological preconditioning on the results of lifting operations efficiency.

Manturova NE, Stupin VA, Smirnova GO, Silina EV.

Heliyon. 2018 Aug 30;4(8):e00758. doi: 10.1016/j.heliyon.2018.e00758. eCollection 2018 Aug.

3.

Validated HPLC-MS/MS method for quantification of ethylmethylhydroxypyridine succinate in rat brain and its application to a pharmacokinetic study.

Melnik EV, Petukhov AE, Kozin SV, Pomerantseva TY, Ramenskaya GV.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Oct 1;1096:180-186. doi: 10.1016/j.jchromb.2018.08.029. Epub 2018 Aug 28.

PMID:
30176507
4.

[An effect of mexidol on the expression of the transcription factor Nrf2 in the rat cerebral cortex in ischemia].

Yakusheva EN, Mylnikov PY, Chernykh IV, Shchulkin AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(5):64-68. doi: 10.17116/jnevro20181185164. Russian.

PMID:
29927406
5.

[Modern strategies of protection of hypoxic-ischemic brain damage].

Yanishevsky SN, Tsygan NV, Golokhvastov SY, Andreev RV, Litvinenko IV, Karpova OS, Yakovleva VA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12. Vyp. 2):78-86. doi: 10.17116/jnevro201711712278-86. Russian.

PMID:
29411750
6.

[Mexidol effect on the factor induced by hypoxia HIF-1α expression in the rat cerebral cortex in ischemia].

Yakusheva EN, Mylnikov PY, Chernykh IV, Shchulkin AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):87-91. doi: 10.17116/jnevro201711710187-91. Russian.

PMID:
29171495
7.

Functional and Biochemical Parameters of Erythrocytes during Mexicor Treatment in Posttraumatic Period after Experimental Blood Loss and Combined Traumatic Brain Injury.

Deryugina AV, Shumilova AV, Filippenko ES, Galkina YV, Simutis IS, Boyarinov GA.

Bull Exp Biol Med. 2017 Nov;164(1):26-29. doi: 10.1007/s10517-017-3918-4. Epub 2017 Nov 9.

PMID:
29119396
8.

[Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].

Stakhovskaya LV, Shamalov NA, Khasanova DR, Melnikova EV, Agafiina AS, Golikov KV, Bogdanov EI, Yakupova AA, Roshkovskaya LV, Lukinykh LV, Lokshtanova TM, Poverennova IE, Shepankevich LA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3. Vyp. 2):55-65. doi: 10.17116/jnevro20171173255-65. Russian.

PMID:
28665371
9.

[Efficiency of cytoflavin in the treatment of somatoform disorders].

Chutko LS, Surushkina SY, Yakovenko EA, Anisimova TI, Prokopenko SM.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(1):21-24. doi: 10.17116/jnevro20171171121-24. Russian.

PMID:
28252599
10.

[Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate].

Prakhova LN, Ilves AG, Savintceva ZI, Mineev KK, Nikiforova IG, Rubanik KS, Kataeva GV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10 Pt 2):73-78. doi: 10.17116/jnevro201611610273-78. Russian.

PMID:
28139615
11.

[An experimental in vitro study of antioxidant and antiradical properties of cytoflavin, vinpocetine, actovegin and ethylmethylhydroxypyridine succinate].

A TS, E DE, A BO, V LN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(7):46-49. doi: 10.17116/jnevro20161167146-49. Russian.

PMID:
27500876
12.

PHARMACOLOGICAL CORRECTION OF MICROCIRCULATION IN RATS SUFFERED A TRAUMATIC BRAIN INJURY.

Bojarinov GA, Deryugina AV, Jakovleva EI, Zajcev RR, Shumilova AV, Bugrova ML, Bojarinova LV, Filippenko ES, Solov’eva OD.

Tsitologiia. 2016;58(8):610-7. English, Russian.

PMID:
30183209
13.

[USING MEXICOR TO CORRECT THE FUNCTIONAL PARAMETERS OF RED BLOOD CELLS IN RATS WITH TRAUMATIC BRAIN INJURY MODEL].

Deryugina AV, Krylov VN, Shumilova AV, Filippenko ES, Boyarinova LV, Solov'eva OD.

Eksp Klin Farmakol. 2015;78(8):14-7. Russian.

PMID:
26591576
14.

[The efficacy of cytoflavin in the treatment of burnout syndrome].

Chutko LS, Surushkina SY, Yakovenko EA, Rozhkova AV, Anisimova TI, Bondarchuk YL.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):66-70. doi: 10.17116/jnevro201511510166-70. Russian.

PMID:
26525625
15.

[COMPARATIVE CARDIOPROTECTIVE EFFICACY OF COENZYME Q10 AND MEXICOR IN EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTION IN RATS].

Kalenikova EI, Tokareva OV, Kulyak OU, Gorodetskaya EA, Medvedev OS.

Eksp Klin Farmakol. 2015;78(6):12-4. Russian.

PMID:
26292508
16.

Effect of phosphocreatine and ethylmethylhydroxypyridine succinate on the expression of Bax and Bcl-2 proteins in left-ventricular cardiomyocytes of spontaneously hypertensive rats.

Azova MM, Blagonravov ML, Frolov VA.

Bull Exp Biol Med. 2015 Jan;158(3):313-4. doi: 10.1007/s10517-015-2749-4. Epub 2015 Jan 9.

PMID:
25573357
17.

[Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type].

Statsenko ME, Turkina SV, Kosivtseva MA.

Klin Med (Mosk). 2013;91(5):59-64. Russian.

PMID:
24159791
18.
19.

[Mexidant increases the effectiveness of levadopa treatment of Parkinson's disease].

Fedorova TN, Bagyeva GKh, Dobrotvorskaia IS, Stepanova MS, Polevaia EV, Ivanova-Smolenskaia IA, Illarioshkin SN.

Eksp Klin Farmakol. 2012;75(6):23-6. Russian.

PMID:
22891437
20.

[Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke].

Chefranova ZhIu, Makotrova TA, Udachin VA, Koledintseva EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(4):49-52. Russian.

PMID:
22810741

Supplemental Content

Loading ...
Support Center